USE OF COMPOUNDS FOR THE TREATMENT OF OBESITY,申请号WO2000DK00514-传众专利搜索

发明名称	USE OF COMPOUNDS FOR THE TREATMENT OF OBESITY
摘要	The present invention relates to the use of compounds that induce Ca<2+> release through the type 1 Ryanodine receptor for the treatment of obesity. The present invention also embraces pharmaceutical compositions comprising these compounds and methods of using the compounds and their pharmaceutical compositions.
申请公布号	WO0222122(A1)	申请公布日期	2002.03.21
申请号	WO2000DK00514	申请日期	2000.09.15
申请人	NOVO NORDISK A/S;BOEHRINGER INGELHEIM INTERNATIONAL, GMBH;NIELSEN, ERIK, BARDRUM;TULLIN, SOEREN;STIDSEN, CARSTEN, ENGGAARD;DIN, NANNI;RAUN, KIRSTEN;FLEDELIUS, CHRISTIAN;BOONEN, HARRIE, C., M.;WIELAND, HEIKE, A.;BARSOUMIAN, EDWARD, LEON;NISHIMURA, SEIICHIRO	发明人	NIELSEN, ERIK, BARDRUM;TULLIN, SOEREN;STIDSEN, CARSTEN, ENGGAARD;DIN, NANNI;RAUN, KIRSTEN;FLEDELIUS, CHRISTIAN;BOONEN, HARRIE, C., M.;WIELAND, HEIKE, A.;BARSOUMIAN, EDWARD, LEON;NISHIMURA, SEIICHIRO
分类号	A61K31/167;A61K31/40;A61K31/428;A61P3/04;(IPC1-7):A61K31/40	主分类号	A61K31/167
代理机构		代理人
主权项
地址